- Did you mean
- cervical intraepithelial neoplasms
Search results - 67 results
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
led to the use of sensitive HPV molecular tests for screening. This study examined the impact of the baseline HPV status on the future risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2 ...
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
retaining vaccination uptake at the current level; vaccinating older women; increasing screening participation; methods for triaging HPV-positive women; improving the diagnosis of cervical intraepithelial ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2 +) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
types and women unselected by HPV status. Expert commentary: All evaluated vaccines offered excellent protection against cervical intraepithelial neoplasia of grade 2 or 3 (CIN2 or CIN3) and ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
1.04) for cervical intraepithelial neoplasia grade 2 or worse (CIN2 +) and 1.01 (95% CI, 0.97 to 1.06) for CIN3 + and relative specificity of 1.02 (95% CI, 1.00 to 1.03) for a CIN grade of ≤1. The ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
Alphapapillomavirus Cervical Intraepithelial Neoplasia Cervix Uteri Diagnostic Tests, Routine DNA, Viral Early Detection of Cancer Female Genotyping Techniques Humans Papillomavirus Infections Uterine Cervical ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
ANALYSIS: We used Cochrane methodology and GRADE to rate the certainty of evidence for protection against cervical precancer (cervical intraepithelial neoplasia grade 2 and above [CIN2 +], CIN grade 3 and ...
Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.
blinded to the clinical data. HPV prevalence was analysed and clinical performance for detection of cervical intraepithelial neoplasia grade 3 or worse (CIN3 +) and CIN2 or worse (CIN2 +) was assessed ...
Pregnancy outcome after cervical conisation: A 2nd retrospective cohort study in the Leuven University Hospital.
consisted of 120 non-treated women who had no history of cervical intra-epithelial neoplasia. Data on smoking status; gestational age at delivery; number of conisations; time interval between treatment and ...
Accuracy of combinations of visual inspection using acetic acid or lugol iodine to detect cervical precancer: a meta-analysis.
visual methods to detect cervical intraepithelial neoplasia grade 2+ (CIN2 +) using: (1) VIA alone; (2) VILI alone; (3) co-testing; and (4) VILI as a triage test of a positive VIA result. SEARCH STRATEGY: ...